Results 71 to 80 of about 13,766 (257)
ABSTRACT Background Candida (Candidozyma) auris has distinct genetic clades. Clade distinction is relevant for infection control and epidemiological purposes. State‐of‐the‐art typing methodologies for clade distinction are based on genomic approaches, such as short tandem repeat (STR) analysis and whole‐genome sequencing (WGS).
Camylla C. de Melo+13 more
wiley +1 more source
Treatment of invasive candidiasis with echinocandins [PDF]
SummaryBlood stream infections by Candida spp. represent the majority of invasive fungal infections in intensive care patients. The high crude mortality of invasive candidiasis remained essentially unchanged during the last two decades despite new treatment options that became available.
Angela Steinbach+3 more
openaire +3 more sources
Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan [PDF]
BackgroundCandida parapsilosis is an emerging non-albicans Candida that is associated with central line-associated infection. C. parapsilosis has higher minimal inhibitory concentration to echinocandin than Candida albicans, and the effects of ...
Hsieh, Feng-Chih+4 more
core +1 more source
Bioactivity‐guided isolation led to the discovery of a potent and selective inhibitor of the phytopathogen Botrytis cinerea, pleosporacin (1), from mycelia extracts of the fungal strain Pleosporales sp. IBWF 020‐21. The biosynthesis of the nonribosomal cyclic lipodepsipeptide 1 was elucidated via heterologous reconstitution in Aspergillus oryzae ...
Carsten Wieder+6 more
wiley +1 more source
Background. Candida tropicalis is a virulent fungal pathogen for which echinocandins are the primary therapy. Emergence of resistance to echinocandins of C. tropicalis carries potentially ominous therapeutic implications. Methods.
Maroun M. Sfeir+8 more
doaj +1 more source
Echinocandin inhibition of 1,3-β-D-glucan synthase from Candida albicans [PDF]
The cyclic peptide antibiotic echinocandin was found to inhibit 1,3-β-D-glucan synthase activity present in a mixed membrane fraction from Candida albicans. Addition of antibiotic reduced the Vmax of the enzyme, but the Km was unaffected.
Kerridge, D.+2 more
core +1 more source
ABSTRACT Device‐related Candida infections are becoming more prevalent, even among immunocompetent individuals. For patients diagnosed with invasive candidiasis, it is essential to perform a fundoscopic examination, irrespective of the presence of ocular symptoms.
Yi Cui+13 more
wiley +1 more source
Rezafungin is a novel echinocandin in Phase 3 development for prevention of invasive fungal disease caused by Candida spp., Aspergillus spp. and Pneumocystis jirovecii in blood and marrow transplantation patients.
Melanie T. Cushion, Alan Ashbaugh
doaj +1 more source
Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
Echinocandin antifungal drugs, including micafungin, anidulafungin, and caspofungin, have been recently reported to exhibit antiviral effects against various viruses such as flavivirus, alphavirus, and coronavirus. In this study, we focused on micafungin
Shogo Nakajima+6 more
doaj +1 more source
The seizure of illicit assets: patterns of civil forfeiture in Canada and Ireland [PDF]
No description ...
Gallant, M Michelle, King, Colin
core +1 more source